Oncoprotein Mechanisms: Prospects in Treatment
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 20 February 2025 | Viewed by 1380
Special Issue Editor
Interests: cancer biology; gene regulation; molecular cloning; cell culture; gene expression; protein biochemistry; bioinformatics and computational biology; cancer cells; PCR; regulation of gene expression
Special Issue Information
Dear Colleagues,
This Special Issue explores emerging findings in oncoproteins in terms of unraveling novel insights into cancer biology. Topics to be covered include the molecular mechanisms underlying the involvement of oncoproteins in cancer progression, their potential as diagnostic markers or therapeutic targets, recent advancements in understanding their interactions within the tumor microenvironment and the role of microsomes/exosomes in tumor biology. This collection aims to foster interdisciplinary discussions, bringing together researchers who push the boundaries of knowledge in harnessing recent knowledge for innovative approaches in cancer diagnosis and treatment.
SPECIFIC TOPICS
- Molecular Mechanisms: Unraveling protein–protein interactions and signaling pathways
Investigations into molecular mechanisms stand at the forefront. Understanding how oncoproteins influence cancer progression requires a comprehensive exploration of the intricate signaling pathways they manipulate, but also of the key relayer of signaling: protein–protein interactions leading phenotypic switching, i.e., the alternative interactions they engage when they are mutated or overexpressed. Thus, unraveling the complex network of protein–protein interactions that underpin aberrant cellular signaling leading to cancerous growth is of crucial importance in identifying novel network targets.
Researchers aim to pinpoint key nodes in these networks where oncoproteins exert their influence. This detailed molecular dissection not only enhances our fundamental knowledge of cancer biology but also provides potential targets for therapeutic interventions. By discerning the molecular dance orchestrated by oncoproteins, scientists pave the way for more precise and effective strategies to combat cancer at its core.
- Therapeutic Targeting: Navigating Toward Precision Medicine
An important avenue in cancer therapeutics revolves around not just the targeted disruption of oncoprotein activities but also, and more importantly, that of cancer networks. Equipped with insights into the molecular intricacies of oncoprotein-driven signaling pathways, researchers assess the feasibility of therapeutic interventions. The spotlight is on developing strategies that specifically target oncoprotein networks, aiming to dismantle the molecular machinery propelling cancerous growth.
Moreover, researchers delve into the roles of interacting oncoproteins in the context of drug addiction and resistance. Understanding how these proteins contribute to the evasion of therapeutic measures is paramount for refining treatment strategies. The quest for precision medicine in cancer therapy hinges on unraveling the specific vulnerabilities introduced by oncoproteins and tailoring interventions to exploit these weaknesses. As oncoproteins become prime targets for therapeutic endeavors, the landscape of cancer treatment is undergoing a paradigm shift towards more precise and effective strategies.
Dr. Nikolaos A. Papanikolaou
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- oncoproteins
- cancer biology
- molecular mechanisms
- therapeutic targeting
- tumor microenvironment
- microsomes/exosomes
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
